3/18
03:12 pm
mxct
MaxCyte, Inc. (NASDAQ: MXCT) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $11.00 price target on the stock.
Low
Report
MaxCyte, Inc. (NASDAQ: MXCT) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $11.00 price target on the stock.
3/18
03:12 pm
mxct
MaxCyte, Inc. (NASDAQ: MXCT) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $11.00 price target on the stock.
Low
Report
MaxCyte, Inc. (NASDAQ: MXCT) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $11.00 price target on the stock.
3/13
12:01 pm
mxct
Rating for MXCT
Medium
Report
Rating for MXCT
3/13
10:20 am
mxct
MaxCyte, Inc. (NASDAQ: MXCT) had its "outperform" rating re-affirmed by analysts at William Blair.
Low
Report
MaxCyte, Inc. (NASDAQ: MXCT) had its "outperform" rating re-affirmed by analysts at William Blair.
3/13
10:20 am
mxct
MaxCyte, Inc. (NASDAQ: MXCT) had its "outperform" rating re-affirmed by analysts at William Blair.
Low
Report
MaxCyte, Inc. (NASDAQ: MXCT) had its "outperform" rating re-affirmed by analysts at William Blair.
3/13
08:01 am
mxct
Rating for MXCT
Low
Report
Rating for MXCT
3/5
11:35 am
mxct
MaxCyte, Inc. (NASDAQ: MXCT) had its "outperform" rating re-affirmed by analysts at William Blair.
Low
Report
MaxCyte, Inc. (NASDAQ: MXCT) had its "outperform" rating re-affirmed by analysts at William Blair.
3/5
11:35 am
mxct
MaxCyte, Inc. (NASDAQ: MXCT) had its "outperform" rating re-affirmed by analysts at William Blair.
Low
Report
MaxCyte, Inc. (NASDAQ: MXCT) had its "outperform" rating re-affirmed by analysts at William Blair.